Literature DB >> 26104118

Molecular targets and pathways involved in liver metastasis of colorectal cancer.

Ulrich H Weidle1, Fabian Birzele, Achim Krüger.   

Abstract

We here summarize the current view of molecular mechanisms involved in the dissemination process of colorectal cancer cells to the liver as deduced from preclinical models. We focus on molecular aspects of the current understanding of the biology of liver metastases formation and survival, both being crucial for identification and validation of possible therapeutic targets and review the latest findings elucidating some features of the liver as a metastatic niche. In more detail, we outline the role of proteases and of major pathways such asc-MET signaling and its modulation by factors such as MACC1 and TIMP1, as well as Notch and TGFβ signaling. The relevance of these signalling pathways during tumor-stroma interactions in this context will be addressed. In addition, the functional role and validation of targets such as PRL3, Trop-2, L1CAM, S100A4, S100P, CD133, LIPC, and APOBEC3G are summarized.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26104118     DOI: 10.1007/s10585-015-9732-3

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  132 in total

Review 1.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

2.  Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein.

Authors:  Ki-Kyung Jung; Xu-Wen Liu; Rosemarie Chirco; Rafael Fridman; Hyeong-Reh Choi Kim
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

3.  Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α.

Authors:  Florian Schelter; Birgit Halbgewachs; Petra Bäumler; Caroline Neu; Agnes Görlach; Florian Schrötzlmair; Achim Krüger
Journal:  Clin Exp Metastasis       Date:  2010-10-30       Impact factor: 5.150

4.  Overexpression of S100A4 is closely associated with progression of colorectal cancer.

Authors:  Yong-Gu Cho; Chang-Jae Kim; Suk-Woo Nam; Shin-Hee Yoon; Sug-Hyung Lee; Nam-Jin Yoo; Jung-Young Lee; Won-Sang Park
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

5.  Identification of a survival-independent metastasis-enhancing role of hypoxia-inducible factor-1alpha with a hypoxia-tolerant tumor cell line.

Authors:  Florian Schelter; Michael Gerg; Birgit Halbgewachs; Susanne Schaten; Agnes Görlach; Florian Schrötzlmair; Achim Krüger
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

6.  Activating SRC mutation in a subset of advanced human colon cancers.

Authors:  R B Irby; W Mao; D Coppola; J Kang; J M Loubeau; W Trudeau; R Karl; D J Fujita; R Jove; T J Yeatman
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

Review 7.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

8.  Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.

Authors:  Nancy Gavert; Michal Sheffer; Shani Raveh; Simone Spaderna; Michael Shtutman; Thomas Brabletz; Francis Barany; Phillip Paty; Daniel Notterman; Eytan Domany; Avri Ben-Ze'ev
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

9.  Prediction of metastasis and recurrence in colorectal cancer based on gene expression analysis: ready for the clinic?

Authors:  Masaki Shibayama; Matthias Maak; Ulrich Nitsche; Kengo Gotoh; Robert Rosenberg; Klaus-Peter Janssen
Journal:  Cancers (Basel)       Date:  2011-07-07       Impact factor: 6.639

10.  Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.

Authors:  Charlotte Kopitz; Michael Gerg; Obul Reddy Bandapalli; Dilek Ister; Caroline J Pennington; Stephanie Hauser; Christin Flechsig; Hans-Willi Krell; Dalibor Antolovic; Keith Brew; Hideaki Nagase; Manfred Stangl; Claus W Hann von Weyhern; Björn L D M Brücher; Karsten Brand; Lisa M Coussens; Dylan R Edwards; Achim Krüger
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

View more
  31 in total

Review 1.  Liver metastases: Microenvironments and ex-vivo models.

Authors:  Amanda M Clark; Bo Ma; D Lansing Taylor; Linda Griffith; Alan Wells
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

2.  Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds.

Authors:  Xi Tian; Michael E Werner; Kyle C Roche; Ariel D Hanson; Henry P Foote; Stephanie K Yu; Samuel B Warner; Jonathan A Copp; Haydee Lara; Eliane L Wauthier; Joseph M Caster; Laura E Herring; Longzhen Zhang; Joel E Tepper; David S Hsu; Tian Zhang; Lola M Reid; Andrew Z Wang
Journal:  Nat Biomed Eng       Date:  2018-04-23       Impact factor: 25.671

Review 3.  microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models.

Authors:  Ulrich H Weidle; Ulrich Brinkmann; Simon Auslaender
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

4.  MACC1 upregulation promotes gastric cancer tumor cell metastasis and predicts a poor prognosis.

Authors:  Qiu-Ping Xie; Cheng Xiang; Gang Wang; Ke-Feng Lei; Yong Wang
Journal:  J Zhejiang Univ Sci B       Date:  2016-05       Impact factor: 3.066

5.  Cortactin and Exo70 mediated invasion of hepatoma carcinoma cells by MMP-9 secretion.

Authors:  Gang Zhao; Hongyi Zhang; Ziming Huang; Liping Lv; Fan Yan
Journal:  Mol Biol Rep       Date:  2016-03-29       Impact factor: 2.316

6.  Up-regulated CKS2 promotes tumor progression and predicts a poor prognosis in human colorectal cancer.

Authors:  Min-Hao Yu; Yang Luo; Shao-Lan Qin; Zheng-Shi Wang; Yi-Fei Mu; Ming Zhong
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

Review 7.  Association between liver targeted antiviral therapy in colorectal cancer and survival benefits: An appraisal.

Authors:  Qiang Wang; Chao-Ran Yu
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

Review 8.  Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer.

Authors:  Wubin Zheng; Fan Wu; Kai Fu; Guangshun Sun; Guoqiang Sun; Xiao Li; Wei Jiang; Hongyong Cao; Hanjin Wang; Weiwei Tang
Journal:  Onco Targets Ther       Date:  2021-05-06       Impact factor: 4.147

Review 9.  Liver Tropism in Cancer: The Hepatic Metastatic Niche.

Authors:  Ainhoa Mielgo; Michael C Schmid
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

10.  Correlation of PRL3 expression with colorectal cancer progression.

Authors:  Premila D Leiphrakpam; Audrey J Lazenby; Lynette M Smith; Michael G Brattain; Jennifer D Black; Jing Wang; Chandrakanth Are
Journal:  J Surg Oncol       Date:  2020-11-12       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.